Clinical Trial Update: Study of FF-10501-01 in Patients With Relapsed or Refractory Hematological Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study of FF-10501-01 in relapsed or refractory hematologic malignancies has completed, with results posted. The diseases studied include acute myeloid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Myelomonocytic Leukemia

Drugs mentioned

• FF-10501-01

Snippet

Sponsor: Fujifilm Pharmaceuticals U.S.A., Inc. | Conditions: AML, CMML | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-03-19